Clinical trial
Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV…
NCT00006591 · Gathe, Joseph, M.D., Other · Unknown status
Key facts
| NCT number | NCT00006591 |
|---|---|
| Title | Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment |
| Official title | The Safety and Efficacy of a Ritonavir-Enhanced Agenerase Regimen as Salvage Therapy in HIV-Infected Individuals |
| Lead sponsor | Gathe, Joseph, M.D., Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Ritonavir, Amprenavir |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: